Patent assignee · US · COMPANY

Ignyta, Inc.

🏢 View company profile →
25Patents
25Active
25Granted
51Portfolio score

Filing activity: Nov 12, 2013 → Apr 14, 2020

Most-cited patents

PatentTitleAreaCited byStatus
US9149464B2 Bendamustine derivatives and methods of using same Chemistry; Metallurgy 26 Active
US9150517B2 Bendamustine derivatives and methods of using same Chemistry; Metallurgy 26 Active
US10231965B2 Molecules for administration to ROS1 mutant cancer cells Human Necessities 7 Active
US10085979B2 Combinations for the treatment of neuroblastoma Chemistry; Metallurgy 7 Active
US9029538B2 Uracil derivatives as AXL and c-MET kinase inhibitors Chemistry; Metallurgy 7 Active
US9120778B2 Uracil derivatives as AXL and c-MET kinase inhibitors Chemistry; Metallurgy 4 Active
US10357490B2 Combinations for the treatment of neuroblastoma Chemistry; Metallurgy 4 Active
US9522902B2 Uracil derivatives as AXL and c-MET kinase inhibitors Chemistry; Metallurgy 3 Active
US9353097B2 Solid state forms of a quinazoline derivative and its use as a BRAF inhibitor Chemistry; Metallurgy 3 Active
US10398693B2 Pharmaceutical compositions and dosage forms Human Necessities 3 Active
US10561651B2 Methods for treating neuroblastoma Human Necessities 3 Active
US9718810B2 Solid state forms of a quinazoline derivative and its use as a BRAF inhibitor Chemistry; Metallurgy 2 Active
US9452988B2 Bendamustine derivatives and methods of using same Chemistry; Metallurgy 2 Active
US11007191B2 Pharmaceutical compositions and dosage forms Human Necessities 1 Active
US10869864B2 Combinations for the treatment of cancer Chemistry; Metallurgy 1 Active
US10682348B2 Molecules for administration to ROS1 mutant cancer cells Human Necessities 1 Active
US9630926B2 Bendamustine derivatives and methods of using same Chemistry; Metallurgy 0 Active
US10799503B2 Methods for the treatment of cancer Human Necessities 0 Active
US9914731B2 Pyrazolo[1,5-a]pyridine derivatives and methods of their use Human Necessities 0 Active
US9987281B2 Solid state forms of a quinazoline derivative and its use as a BRAF inhibitor Chemistry; Metallurgy 0 Active
US10028956B2 Methods of treating various cancers using an AXL/cMET inhibitor in combination with other agents Human Necessities 0 Active
US10017496B2 Uracil derivatives as AXL and c-MET kinase inhibitors Chemistry; Metallurgy 0 Active
US9913827B2 Bendamustine derivatives and methods of using same Chemistry; Metallurgy 0 Active
US11253515B2 Pharmaceutical compositions and dosage forms Human Necessities 0 Active
US9745283B2 Uracil derivatives as AXL and c-MET kinase inhibitors Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.